Literature DB >> 19844707

Progress and challenges in neuroendocrine and neural crest tumours: molecular imaging and therapy.

Giovanni Lucignani1, Emilio Bombardieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19844707     DOI： 10.1007/s00259-009-1286-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  19 in total

1.  Tumor imaging and therapy using radiolabeled somatostatin analogues.

Authors:  Marion de Jong; Wout A P Breeman; Dik J Kwekkeboom; Roelf Valkema; Eric P Krenning
Journal:  Acc Chem Res       Date:  2009-07-21       Impact factor: 22.384

2.  Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors.

Authors:  Etienne Garin; Florence Le Jeune; Anne Devillers; Marc Cuggia; Anne-Sophie de Lajarte-Thirouard; Catherine Bouriel; Eveline Boucher; Jean-Luc Raoul
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

3.  18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.

Authors:  Farzin Imani; Vatche G Agopian; Martin S Auerbach; Martin A Walter; Firoozeh Imani; Matthias R Benz; Rebecca A Dumont; Chi Kien Lai; Johannes G Czernin; Michael W Yeh
Journal:  J Nucl Med       Date:  2009-03-16       Impact factor: 10.057

4.  Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.

Authors:  Daniel Putzer; Michael Gabriel; Benjamin Henninger; Dorota Kendler; Christian Uprimny; Georg Dobrozemsky; Clemens Decristoforo; Reto Josef Bale; Werner Jaschke; Irene Johanna Virgolini
Journal:  J Nucl Med       Date:  2009-07-17       Impact factor: 10.057

Review 5.  Peptide-receptor radionuclide therapy for endocrine tumors.

Authors:  Martijn van Essen; Eric P Krenning; Boen L R Kam; Marion de Jong; Roelf Valkema; Dik J Kwekkeboom
Journal:  Nat Rev Endocrinol       Date:  2009-06-02       Impact factor: 43.330

Review 6.  Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results.

Authors:  Klaas P Koopmans; Oliver N Neels; Ido P Kema; Philip H Elsinga; Thera P Links; Elisabeth G E de Vries; Pieter L Jager
Journal:  Crit Rev Oncol Hematol       Date:  2009-04-09       Impact factor: 6.312

7.  Manipulation of [11C]-5-hydroxytryptophan and 6-[18F]fluoro-3,4-dihydroxy-L-phenylalanine accumulation in neuroendocrine tumor cells.

Authors:  Oliver C Neels; Klaas P Koopmans; Pieter L Jager; Laya Vercauteren; Aren van Waarde; Janine Doorduin; Hetty Timmer-Bosscha; Adrienne H Brouwers; Elisabeth G E de Vries; Rudi A J O Dierckx; Ido P Kema; Philip H Elsinga
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

8.  68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid.

Authors:  Valentina Ambrosini; Paolo Castellucci; Domenico Rubello; Cristina Nanni; Alessandra Musto; Vincenzo Allegri; Gian Carlo Montini; Sandro Mattioli; Gaia Grassetto; Adil Al-Nahhas; Roberto Franchi; Stefano Fanti
Journal:  Nucl Med Commun       Date:  2009-04       Impact factor: 1.690

9.  Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate.

Authors:  Flavio Forrer; Eric P Krenning; Peter P Kooij; Bert F Bernard; Mark Konijnenberg; Willem H Bakker; Jaap J M Teunissen; Marion de Jong; Kirsten van Lom; Wouter W de Herder; Dik J Kwekkeboom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-27       Impact factor: 9.236

Review 10.  Update on nuclear medicine imaging of neuroendocrine tumors.

Authors:  Stanley J Goldsmith
Journal:  Future Oncol       Date:  2009-02       Impact factor: 3.404
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.